Cargando…
Imepitoin Shows Benzodiazepine-Like Effects in Models of Anxiety
Imepitoin is a low affinity partial agonist for the benzodiazepine binding site of γ-aminobutyric acid (GABA(A)) receptors, and is currently used as an antiepileptic in dogs. Here we tested imepitoin for anxiolytic properties. In an in vitro model, imepitoin was capable of preventing the effect of c...
Autores principales: | Engel, Odilo, Masic, Aleksandar, Landsberg, Gary, Brooks, Melissa, Mills, Daniel S., Rundfeldt, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230983/ https://www.ncbi.nlm.nih.gov/pubmed/30455643 http://dx.doi.org/10.3389/fphar.2018.01225 |
Ejemplares similares
-
Effectiveness of imepitoin for the control of anxiety and fear associated with noise phobia in dogs
por: Engel, Odilo, et al.
Publicado: (2019) -
Imepitoin is well tolerated in healthy and epileptic cats
por: Engel, Odilo, et al.
Publicado: (2017) -
Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy
por: Neßler, Jasmin, et al.
Publicado: (2017) -
Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs
por: Rundfeldt, C, et al.
Publicado: (2014) -
Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up
por: Rundfeldt, Chris, et al.
Publicado: (2015)